Visual Abstract: Ipilimumab vs FOLFOX in ERBB2-Positive Esophagogastric Adenocarcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2228?guestAccessKey=88a81f35-fbee-41a3-a7fc-574429ec2cf4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322 Visual Abstract…
Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race, Ethnicity
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1990?guestAccessKey=3d042976-b580-42b8-a1f0-341ff4cef611&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322 About The Study: This study of 45,000…
Environmental Outcomes Associated With Transition From In-Person to Virtual Conference During COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1925?guestAccessKey=9cff5e2e-0789-4421-be52-8d3dd58455a9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322 About The Study: Researchers estimated the change in travel-related…
JAMAONCO_OF:06162022
Visual Abstract: Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1641?guestAccessKey=27101ae2-0299-4636-ae46-9e6c928e13e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622 Visual Abstract…
Visual Abstract: Efficacy of Pegasparaginase-Based Chemotherapy Regimen vs L-asparaginase–Based Regimen for Extranodal Natural Killer/T-Cell Lymphoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1968?guestAccessKey=e677efdb-e05c-46f6-9c45-8250fba74408&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622 Visual Abstract…
Assessing Risk of Maternal Death in Pregnancies Complicated by Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1795?guestAccessKey=53666fe6-8c61-4ef6-8aa1-925d724bbda0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622 About The Study: Researchers examined nationwide trends and characteristics…
JAMAONCO_OF:06092022
Risk Factors, Racial, Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1628?guestAccessKey=f59cfb53-9e1c-4d40-8d10-0d77617ef26c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922
Assessment of Compliance With Centers for Medicare & Medicaid Services Price Transparency Final Rule
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1783?guestAccessKey=ed7608dc-a4c6-4f38-b178-fbec153a9283&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922
JAMAONCO_OF:06022022
JAMAONCO_OF:05262022
Visual Abstract: Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 26, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1479?guestAccessKey=b74760fc-69e3-4e2a-83f2-8d34a94ca3b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052622 Visual Abstract…
JAMAONCO_OF:05242022
JAMAONCO_OF:05192022
Change in Cancer Death Rates Among Black Individuals in US
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 19, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1472?guestAccessKey=4f8298ee-74af-4722-870e-e774477e130c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051922 About The Study: Researchers found in this cross-sectional study…
JAMAONCO_OF:05122022
Visual Abstract: Efficacy of Vistusertib With Anastrozole in Recurrent or Metastatic Endometrial Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1047?guestAccessKey=7ceee02b-5633-46ea-8090-de65d98f5d50&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222 Visual Abstract Authors: Pierre…
Visual Abstract: Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer, Brain Metastases
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0514?guestAccessKey=d16b2127-1557-410e-9965-0bfac3675cb4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222 Visual Abstract Authors: Debu…
JAMAONCO_OF:05052022
Racial, Ethnic Differences in Uterine Cancer Mortality Rates
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0009?guestAccessKey=bc521263-d45e-4eb6-8531-4b0b890fd93e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522 About The Study: This study of 208,000 women showed…
Age at Initiation of Endoscopy, Colorectal Cancer Risk Among Women
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0883?guestAccessKey=8acc231b-cf2a-4115-ae46-e34a7f3d6497&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522 About The Study: Compared with no endoscopy,…
JAMAONCO_OF:04282022
JAMAONCO_ADHOC:04222022
Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1467?guestAccessKey=a314a6bb-e264-4ade-86c3-0e104b8f74f9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042222
JAMAONCO_OF:04212022
Durability of Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0752?guestAccessKey=bed65c33-3051-450a-9874-e6858923afd2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042122
JAMAONCO_OF:04142022
JAMAONCO_ADHOC:04082022
Breakthrough SARS-CoV-2 Infections, Hospitalizations, Mortality in Vaccinated Patients With Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1096?guestAccessKey=da1de153-897a-41d6-80f6-14ae617e331a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040822
JAMAONCO_OF:04072022
Association of Medicaid Expansion With Mortality Disparity by Race, Ethnicity Among Patients With De Novo Stage IV Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0159?guestAccessKey=acc01b6e-19ef-42f0-863a-7fcbda037aa6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722
Association of Pandemic With Rates of Prostate Cancer Biopsies, Diagnoses in Black vs White US Veterans
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0467?guestAccessKey=92f3e2d1-bd5c-46de-bd55-7c4bb72dcb11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722 What The Study Did: Prostate biopsy and prostate cancer…
JAMAONCO_OF:03312022
Visual Abstract: TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 31, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3547?guestAccessKey=8d9bd1e6-f049-42d7-afe3-9c8e25f2daa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122 Visual Abstract Authors: Robin…
Association of Patient-Reported Outcomes With Nonfatal Self-injury After New Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0203?guestAccessKey=00e63a17-6219-47bf-8c53-40a8bd9f6638&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122
Association of Changes in Medicaid Dental Benefits With Oral Cavity Cancer Diagnosis
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0149?guestAccessKey=6a711b05-104d-497e-9fc0-b0f83e4f049d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=033122
JAMAONCO_OF:03242022
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0143?guestAccessKey=5cf125ad-4c75-4c74-8fa2-7e2cc23d7191&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422
Visual Abstract: Paclitaxel, Cisplatin, Capecitabine vs Cisplatin, Fluorouracil for Nasopharyngeal Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0122?guestAccessKey=0dbfee8b-21aa-4dba-9124-1cad55464019&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=032422 Visual Abstract…
JAMAONCO_OF:03172022
Risk of Colorectal Cancer Associated With Lifetime Excess Weight
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 17, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0064?guestAccessKey=f7acd72a-cef3-4048-b6f5-c79e1a5df966&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031722 What The Study Did: A greater number…
JAMAONCO_OF:03102022
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0001?guestAccessKey=28a28d85-7f85-427c-b826-d89f6a8ecb4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031022
JAMAONCO_OF:03032022
Factors Associated With Racial Disparity in Use of MRI Among Patients With Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8116?guestAccessKey=de4ed44c-76d6-4a00-8162-6f8f7fc66096&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322 What The Study Did: This study of…
Visual Abstract: Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 3, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.8171?guestAccessKey=89bc130b-ab40-4ac6-88e6-4f65d4a27e5d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=030322 Visual Abstract Authors:…
JAMAONCO_OF:02242022
Visual Abstract: Palliative Radiation for Advanced Central Lung Tumors With Avoidance of the Esophagus
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 24, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7664?guestAccessKey=553a7379-6e75-4459-92c7-2ab0b6d97fea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=022422 Visual Abstract…
Racial Disparity in Survival Outcomes for Early Hormone Receptor–Positive Breast Cancer
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7656?guestAccessKey=d9c22bbb-19ef-4c43-85f7-afc06c85febc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722
Visual Abstract: Capecitabine Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 17, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7366?guestAccessKey=1105ab84-3fa2-4968-8fc0-a0a004c7679a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021722 Visual Abstract…
JAMAONCO_OF:02172022
Visual Abstract: Autologous Dendritic Cell Immunotherapy Plus Chemotherapy in Metastatic Castration-Resistant Prostate Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7298?guestAccessKey=917838c5-d533-4d82-982c-5950df33843b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022 Visual Abstract…
Visual Abstract: Effect of Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 10, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7643?guestAccessKey=37d42b48-589a-4d9b-82cc-956b70090d11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022 Visual Abstract Authors:…
Association of HPV Vaccination, Incidence of Squamous Cell Carcinomas of Anus
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7652?guestAccessKey=c9a9b5b2-3c4c-405e-8021-ff8ccc302036&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021022
JAMAONCO_OF:02102022
JAMAONC_OF:02032022
JAMAONCO_OF:01272022
Geographic Disparities in Treatment of Curable Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 27, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7337?guestAccessKey=7a16d9be-1ed0-42ab-bdbd-f456a1f31f88&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012722 What The Study Did: The extent to which geographic…
JAMAONCO_OF:01202022
JAMAONCO_OF:01132022
Comparing Lung Cancer Screening Criteria for Racial Disparity in Eligibility
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 13, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6720?guestAccessKey=46113213-0bcc-4a03-a1c3-c4ea5e7383a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011322 What The Study Did: The findings of…
JAMAONCO_ADHOC:01072022
SARS-CoV-2 Antibody Response to 2 or 3 Doses of BioNTech-Pfizer Vaccine in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JANUARY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.7777?guestAccessKey=64f57de0-65f5-4ccc-9c30-3abe123b5e3b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010722 What The Study Did: This study assessed the antibody…
Visual Abstract: Comparing Prophylactic Antibiotic Regimens After Endoprosthetic Reconstruction for Lower Extremity Bone Tumors
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6628?guestAccessKey=83a5b584-1fa5-48e4-82a9-28d957bdab6d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622 Visual Abstract…
JAMAONCO_OF:01062022
Association of Sitting Time, Physical Activity With Cancer Survival
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 6, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6590?guestAccessKey=8b888a7b-1d4c-4ddc-94cb-2cd1ef14deb9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010622 What The Study Did: Researchers examined the associations of…
JAMAONCO_OF:12302021
Global Burden of Cancer, 2010 to 2019
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6987?guestAccessKey=de848f90-c09a-4361-9e2a-fe2c6562d9a2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=123021
JAMAONCO_OF:12232021
Visual Abstract: Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 23, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5981?guestAccessKey=f7d45c3d-a78d-4435-a89c-fb8eb9afa57d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122321 Visual Abstract Authors:…
JAMAONCO_OF:12162021
JAMAONCO_OF:12092021
Diversity Among US Radiation, Medical Oncology Faculty
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 9, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6011?guestAccessKey=bb9a9220-1bbf-4ab2-96f9-b077e4984ff8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120921 What The Study Did: The results of…
JAMAONCO_OF:12022021
Effectiveness of COVID-19 Vaccination in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 2, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5771?guestAccessKey=5fcd8b60-734c-4f79-8c52-139d4f069eac&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120221 What The Study Did: In this study of Veterans…
JAMAONCO_OF:11242021
Association Between Neighborhood Socioeconomic Inequality, Cervical Cancer Rates in New York City
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5779?guestAccessKey=875a08ed-82ac-42d8-befe-cd94de00c5cd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: In this population-based, cross-sectional study, researchers…
Eligibility of Black Women Under USPSTF Lung Cancer Screening Guidelines
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5790?guestAccessKey=988b5b64-a314-4333-ab42-05e8abd58fe2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: Researchers evaluated lung cancer screening eligibility…
Change in COVID-19 Mortality in Patients With Cancer During Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 24, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6199?guestAccessKey=34bfddf6-8dcb-4cc5-b112-3792eda89ee4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421 What The Study Did: Evolving outcomes of COVID-19 in patients…
Outcomes of Screening for Prostate Cancer Among Men Who Use Statins
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5672?guestAccessKey=b34f9b8a-3809-4044-9079-510749446219&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112421
JAMAONCO_OF:11232021
Assessing Response to Third Dose of SARS-CoV-2 BNT162b2 Vaccine in Patients With Solid Tumors
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6764?guestAccessKey=fa2f67e0-5398-479e-9c84-040b27818f41&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112321
JAMAONCO_OF:11182021
Telemedicine Use by Socioeconomic Status Among Patients With Newly Diagnosed Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5784?guestAccessKey=1bebfa23-1ea5-41a2-ab62-02ba8f55f0b5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821 What The Study Did: Researchers found that among 16,000…
Visual Abstract: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 18, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5445?guestAccessKey=9e2e2632-3143-4a5a-bff7-c19a1983fea5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821 Visual Abstract Authors:…
T-Cell Responses to SARS-CoV-2 Vaccines in Patients With B-Cell Depletion
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6030?guestAccessKey=d5abc9d4-27a3-4f58-bb04-59ee7ca15a4c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111821
JAMAONCO_11112021
Progress Against Cancer Deaths 50 Years After National Cancer Act Passed
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5668?guestAccessKey=fa22406b-0c85-463b-a38f-8a0bcd08f48f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111121 What The Study Did: This year is the 50th anniversary…
JAMAONCO_OF:11042021
JAMAONCO_OF:10282021
COVID-19 Death, Adverse Outcomes in Patients With, Without Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 28, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.5148?guestAccessKey=f51f92f4-9ae3-44f9-a1b1-659a3d763658&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102821 What The Study Did: In this study of more than…
JAMAONCO_OF:10252021
Visual Abstract: Effect of Elective Internal Mammary Node Irradiation on Disease-Free Survival in Women With Node-Positive Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 5:05 P.M. (ET), MONDAY, OCTOBER 25, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.6036?guestAccessKey=fccdc560-4934-481d-954a-55b6eb373e97&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102521 Visual Abstract Authors: Chang-Ok…
JAMAONCO_OF:10212021
JAMAONCO_OF:10142021
Visual Abstract: Fulvestrant-Palbociclib vs. Letrozole-Palbociclib as Initial Therapy for Advanced Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 7, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4301?guestAccessKey=4c8d31e5-75de-4219-ac23-dc4434ce706d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=100721 Visual Abstract Authors:…